* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download practicle guidelines for treating mental disorders in
History of psychosurgery in the United Kingdom wikipedia , lookup
Rumination syndrome wikipedia , lookup
Excoriation disorder wikipedia , lookup
Anxiety disorder wikipedia , lookup
Pyotr Gannushkin wikipedia , lookup
Glossary of psychiatry wikipedia , lookup
Asperger syndrome wikipedia , lookup
Antipsychotic wikipedia , lookup
Antisocial personality disorder wikipedia , lookup
Moral treatment wikipedia , lookup
Bipolar disorder wikipedia , lookup
Depersonalization disorder wikipedia , lookup
Mental status examination wikipedia , lookup
Schizoaffective disorder wikipedia , lookup
Major depressive disorder wikipedia , lookup
Mental disorder wikipedia , lookup
Conduct disorder wikipedia , lookup
Separation anxiety disorder wikipedia , lookup
Panic disorder wikipedia , lookup
Spectrum disorder wikipedia , lookup
Causes of mental disorders wikipedia , lookup
Classification of mental disorders wikipedia , lookup
Diagnostic and Statistical Manual of Mental Disorders wikipedia , lookup
Dissociative identity disorder wikipedia , lookup
Bipolar II disorder wikipedia , lookup
Conversion disorder wikipedia , lookup
Narcissistic personality disorder wikipedia , lookup
Controversy surrounding psychiatry wikipedia , lookup
History of psychiatric institutions wikipedia , lookup
Child psychopathology wikipedia , lookup
Emergency psychiatry wikipedia , lookup
Generalized anxiety disorder wikipedia , lookup
History of psychiatry wikipedia , lookup
Abnormal psychology wikipedia , lookup
PRACTICAL GUIDELINES FOR TREATING MENTAL DISORDERS IN KENYAN GENERAL MEDICAL FACILITIES SUMMARY: 1) MOOD DISORDERS: a) Major Depressive Disorder: Amitriptilyne (Fluoxetine) b) Bipolar Disorder: Carbamazepine (Haloperidol) 2) ANXIETY DISORDERS: a) Generalized Anxiety Disorder: Amitriptilyne, (alprazolam) b) Panic Disorder: Amitriptilyne (alprazolam) c) Post traumatic Stress Disorder: fluoxetine (amitriptilyne) d) Obsessive Compulsive Disorder: Amitriptilyne (fluoxetine) e) Prompt control of severe anxiety symptoms or epileptic seizures: diazepam 3) PSYCHOSOMATIC DISORDERS: a) Migraine: prophilaxys with amitriptilyne (propanolol) / Acute treatment: Rizatriptan, Pain Killers b)Tension-Type Headache: prophilaxys with amitriptilyne (propanolol) c) Pain disorder (gastric, back, arm pain etc..): amitriptyline 4) INSOMNIA: Zolpidem (Alprazolam) or Diazepam 5) SUBSTANCE ABUSE AND DEPENDENCE DISORDERS 6) SCHIZOPHRENIA: Haloperidol (Clorpromazine) NB: Refer all patients for counseling after done a diagnose of any Mental disorder (soft Schizophrenia and Bipolar disorder in acute psychotic phase and patients with very low insight). Send them to the reception of Ruaraka UIhai Neema Hospital to arrange an appointement (on Tuesday or Thurday) - If counseling would be not available in our hospital refer patients, with a letter in which you specify the diagnose, to Keniatta National Hospital: Patients Support Centre, near Orthopedyc clinic n.5 , tel 02726300 , email: [email protected] (300 Sh for the file/ 350 Sh for 1 hour counseling ) - If patient needs Psychiatric counsultation: Refer to Mathari Hospital outpatients clinic (50 Sh for the visit) - If Children with Mental problems: Refer to Mathari Hospital for Children Psychiatric Assessment and counseling (Only on Wednesday: 50 Sh) ALGHORITM for INTEGRATING BASIC PSYCHIATRIC CARE AT NEEMA HOSPITAL - Patient at Triage: Screening for Major Depressive Episode (MDE): No MDE STOP During the past two weeks, have you been consistently depressed, down, or less interested in most things, most of the day, nearly every day? Risk MDE: Doctor checks if criteria for MDE are present (with MINI-plus): No criteria STOP Yes criteria MDE and you exclude a past hypomani/manic episode (with MINI-plus): Diagnose of MAJOR DEPRESSIVE DISORDER (MDD) Refer for COUNSELING always (appointement at the reception) FARMACOLOGIC TREATMENT if there is the need (see these guidelines) For other most common diseases (Pain Disorder, Bipolar Disorder, Generalized Anxiety Disorder, Panic Disorder, Post Traumatic Stress disorder) repeat the same alghoritm, but without the screening at triage. Please, if you have not time to do a psychiatric diagnose but it seem you that the patient had a risk for some mental disorder refer him to counseling for a more comprehensive assessment, specifying the diagnose that you suspect. 1) MOOD DISORDERS 1A) MAJOR DEPRESSIVE DISORDER (only Major Depressive Episodes, at least one) a) Preliminary Assessment: - Exclude organic illness (Hypothyroidism, diabetes, cancer, neurological disease) - Exclude Substance abuse disorder - Medical and psychiatric history - Physical and neurologic examination Ask for - Mental status assessment suicidality!!! - Diagnose b) 1st steps: - Information - Empathetic listening - Reassurance - Psychological support (e.g. problem solving counselling) - referral to relevant social services and resources in the community. c) When To use Antidepressants? (if not only counseling) - Moderate to severe Major depressive Episode Functional impairment Long duration of illness (+ 2months)/ Remittent course Severe somatic complains / concomitant chronic ilness Alcol or substance abuse Familiarity for mood disorders Psychotic symptoms d) Amitriptyline 25-50 mg nocte If Contraindication Not tollerate side effects Fluoxetine 20 mg OD + Counseling Contraindication: : Pregnancy and breast feeding, Glaucome, hyperthyroidism, prostatic hypertrophy, Stenosis pillorica, heart failure, serious rhythm disturbances, Hypotension,treatment with thyroid ormons, liver diseases, Dementia. Common adverse effects: dry mouth, constipation, urinary retention, blurred vision and disturbances in accommodation, increased intra-ocular pressure, hyperthermia, drowsiness and increased appetite with weight gain, orthostatic hypotension, tachycardia, sexual dysfunction. Serious adverse effects: electrocardiogram changes, confusion or delirium, hyponatraemia associated with inappropriate secretion of antidiuretic hormone, peripheral neuropathy, tremor, ataxia, dysarthria, convulsions. Severity of Major Depressive Episode: Contraindication: Pregnancy and breast feeding, Hypersensibility Common adverse effects: gastrointestinal disturbances such as nausea, vomiting, dyspepsia, constipation, diarrhoea, anorexia, weight loss, anxiety, restlessness, nervousness, insomnia; headache, tremor, dizziness, agitation, sexual dysfunction Serious adverse effects: convulsions, hallucinations, extrapyramidal effects, depersonalisation, panic attacks, hyponatraemia associated with inappropriate secretion of antidiuretic hormone, bleeding disorders, electrocardiogram changes. Important!! - Less dosage in elders - Inform patients about side effect and that the benefits of the theraphy will started after 3-4 weeks. - Inform the patients that is a long term theraphy. Not interrupt it when they will feel better because there is a high risk of relaps. 1B) BIPOLAR DISORDER (MDE current or past + Hypomanic episode current or past or at least one Manic Episode) I) DEPRESSIVE EPISODE and Long Term Treatment Controindication: serious liver, kidney, heart disease, history of aplasia, pregnancy. Common adverse effects: dizziness, drowsiness, ataxia, visual disturbances, confusion, agitation, nausea, vomiting, constipation, leukopenia and other blood disorders, erythematous rash, cholestatic jaundice, hepatitis. Serious adverse effects: Stevens-Johnson syndrome, toxic epidermal necrolysis, hyponatraemia, agranulocytosis, cardiac conduction disturbances, renal failure. symptoms of carbamazepine overdose: include somnolence, tachycardia, atrioventricular conduction defects, seizures, coma, nystagmus, hyporeflexia or hyperreflexia, rigidity, orofacial dyskinesia, and mild respiratory depression. NB: Before and during carbamazepine therapy, monitoring: - Full blood count - Liver and renal function tests - Pregnancy test. If not feasible - Regularly medical examination - Neurologic examination - Recent medical history that may help recognize symptoms suggesting the development of blood or renal or hepatic abnormalities. II) HYPOMANIC EPISODE: ACUTE TREATMENT: Haloperidol 5-10 mg nocte PO + Carbamazepine 200 mg nocte (see 1b.I) Resolution of Hypomanic Episode LONG TERM TREATMENT: Continue only with Carbamazepine (see 1b.I) III) MANIC EPISODE: ACUTE TREATMENT: Haloperidol 10 mg IM or Chlorpromazine: 150-200 mg IM Untill patient can not be managed PO POST-ACUTE TREATMENT: Haloperidol 5-10 mg Nocte PO + Carbamazepine (see 1b.I) Resolution of Manic Episode LONG TERM: Carbamazepine (see 1b.I); if not enough add Haloperidol 5-10 mg Nocte PO NB: If Haloperidol is not avaible use Chlorpromazine 100 mg Nocte If Problems or the patient is not recovering refer to Psychiatrist. 2) ANXIETY DISORDERS 2A) GENERALIZED ANXIETY DISORDER: I) Empathic listening, reassurance and guidance II) Counseling (cognitive-behavioural Psychoterapy) + Relaxation Techniques III) Short term theraphy: -Only if patients suffer to much that cannot do counseling without. The objective may be to reduce symptoms enough to allow the patient to engage in treatments based on cognitive-behavioural techniques. Lowest effective dose for as short a period as possible (maximum 3-4 weeks). Then decrease gradually. Alprazolam: 0,25 mg BD/TDS (up to 1-2 mg BD/TDS) or Diazepam: 2 mg BD/TDS, up to 5 TDS or 10 mg BD. less dependance an sedation than Diazepam IV) Long Term theraphy: - If the disorders is severe, disabling and causing extreme distress, or that have somatic symptoms or that not responding to psychotherapy, or there is no possibility of Psychotherapy. Amitriptyline (or fluoxetine) as in Depression (see 1d) 2B) PANIC DISORDER: Same therapy than Generalized Anxiety Disorder (See 2a-I/III), but, if you need to use Benzodiazepine try first to istruct the patients to use the medicines only when the panic attac will come (or it’s almost to come): - Alprazolam: 0,5 mg or - Diazepam 5mg 2C) POST TRAUMATIC STRESS DISORDER: Same therapy than Generalized Anxiety disorder (See 2a-I/III ), but if patients can afford Fluoxetine is the better choice. If the disturb follow a recent trauma (ACUTE STRESS DISORDER), and the disorders is severe, disabling and causing extreme distress, start with an antidepressant + benzodiazepine. 2D) OBSESSIVE COMPULSIVE DISORDER I) II) Gold Standard: Cognitive-behavioural therapy (CBT) If it’s no possibile CBT: Amytriptiline or Fluoxetine at high dosages. IIa) Amitriptyline at high dosage: 75 mg nocte: After 2 weeks 1st week: start with 50 mg 2nd week + 25 mg monitoring acute effects After 3 Months: Evaluation of treatment response (follow alghoritm for depression: see 1d) IIb) Fluoxetine at high dosage: 40-60 mg nocte: After 2 weeks monitoring acute effects 1st week: start with 20 mg 2nd week + 20 mg After 3 Months: Evaluation of treatment response (follow alghoritm for depression: see 1d) 2E) PROMPT CONTROL OF SEVERE ANXIETY SYMPTOMS: - Diazepam 2-10 mg intramuscular or intravenous injection (repeated after 3-4 hours if needed) NB: If Anxiety Disorder are associated with depression or with somatic syntoms use immediatly Amitriptyline. Low dosage of Benzodiazepines are request in Children and Elder Contraindications of Benzodiazepines: DIAZEPAM: Pregnancy and Breast feeding, Miastenia gravis, respiratory insufficiency ALPRAZOLAM, ZOLPIDEM: Pregnancy and Breast feeding Common adverse effects of Diazepam: drowsiness, sedation, muscle weakness. Diazepam can adversely affect parameters of driving performance in healthy subjects. Serious adverse effects of Diazepam: vertigo, headache, confusion, depression, dysarthria, changes in libido, tremor, visual disturbances, urinary retention or incontinence, gastrointestinal disturbances, changes in salivation, and amnesia. Some patients may experience a paradoxical excitation which may lead to hostility, aggression, and disinhibition. Jaundice, blood disorders, and hypersensitivity reactions have been reported rarely. Respiratory depression and hypotension occasionally occur with high dosage and parenteral administration. 3) PSYCHOSOMATIC DISORDERS 3A) MIGRAINE How to recognize Migraine? - Last 4-72h Pounding unilateral headache Preceded by visual or other aura Nausea or vomiting Light and sound sensitivity I) ACUTE TREATMENT: 1ST STEP: Oral Analgesics Antiemetic ± Paracetamol 1g BD/TDS or Ibuprofen 400 mg q3-4h or Naproxen 220-550 mg BD 2ND STEP: Parenteral Analgesics Metoclopramide 10 mg PO Parenteral Antiemetic ± Diclofenac IM 75 mg (3ml) Metoclopramide 10 mg (3ml) IM 3RD STEP: Rizatriptan 5-10 mg PO at onset, may repeat after 2h (max 30 mg/d) Contraindication Rizatriptan: ischemic heart disease (e.g., angina pectoris, history of myocardial infarction, or documented silent ischemia) or other significant underlying cardiovascular disease, uncontrolled hypertension, hypersensitive to rizatriptan, concomitant use of another 5-HT1 agonist, ergotamine-containing medication or MAO, hemiplegic or basilar migraine. II) LONG TERM TREATMENT: prophilaxys Amitriptyline 12,5 mg nocte + up to 75 mg if no response Physiotherapy Exercises and Cognitive-Behavioural Therapy (add 25 every 3 weeks) Better if associated: Depression, Chronic pain, Disturbed Sleep, Tension-type headache or Propanolol 40-120 mg BD or Atenolol 25-50 mg OD IF NOT RESPONDING: Amitriptyline + Propanolol 3B) TENSION-TYPE HEADACHE (TTH) How to recognize TTH? Can be Chronic (also everyday) Bilateral No aura No nausea or photophobia No pulsation I) ACUTE TREATMENT: Ia) Infrequent episodic TTH (-2 days/week) Paracetamol 1g BD-TDS + Physiotherapy Exercises and Cognitive-Behavioural Therapy or Ibuprofen 400 mg q3-4h Also alone if headache is not to much severe and persistent (benefits after 1/12. Continue at least 6/12) or Codeine Ib) Chronic TTH (+2 days/week) Amitriptyline 12,5 mg nocte + up to 75 mg if no response (add 25 every 3 weeks) Better if associated: Depression, Chronic pain, Disturbed Sleep, Tension-type headache or Physiotherapy Exercises and Cognitive-Behavioural Therapy A l s o a OD or Atenolol 25-50 mg l o Symptomatic treatment only for short time (consider ancourse of Naproxen 220-550 mg BD) e Propanolol 40-120 mg BD 3C) PAIN DISORDER (gastric, back, leg, chest pain etc..)if Definition: Symptoms suggest a physical disorder, not adequately beHexplained physiologically, esacerbated by stress and psychological problems. e a Amitriptyline 25 mg nocte 1/12 + Counseling d a If Responding: continue at least 6 months c If not responding: + dosage (as in Depression; see Alghoritm 1d) h e i s 4) INSOMNIA 1ST STEP: Sleep Igiene and Relaxation exercises If Severe Insomnia or not response after 1month of non-farmacologic intervention 2nd STEP: Farmacologic Treatment + counseling I) Difficult fall asleep (no anxiety during day) ULTRA SHORT-ACTING: Zolpidem 5-10 mg PO nocte SHORT-ACTING: Alprazolam: 0,25 mg nocte, up to 2 mg Less Dependence, Sedation II) Early weakening (often associated with depression): Not associated with depression: LONG ACTING: Diazepam: 2,5 mg PO nocte, up 5-10 mg Associated with Depression: Amitriptyline 25 mg nocte 1/12 (as in Depression, see alghoritm 1d) NB: At first use Benzodiazepines only at need (when patients is in the bed for several hours and cannot sleep in any way) to help non farmacologic interventions. Afterwards use the lowest effective dose for as short a period as possible (maximum 3 weeks). Then decrease gradually. Contraindications of Benzodiazepines: DIAZEPAM: Pregnancy and Breast feeding, Miastenia gravis, respiratory insufficiency ALPRAZOLAM, ZOLPIDEM: Pregnancy and Breast feeding Common adverse effects of Diazepam: drowsiness, sedation, muscle weakness. Diazepam can adversely affect parameters of driving performance in healthy subjects. Serious adverse effects of Diazepam: vertigo, headache, confusion, depression, dysarthria, changes in libido, tremor, visual disturbances, urinary retention or incontinence, gastrointestinal disturbances, changes in salivation, and amnesia. Some patients may experience a paradoxical excitation which may lead to hostility, aggression, and disinhibition. Jaundice, blood disorders, and hypersensitivity reactions have been reported rarely. Respiratory depression and hypotension occasionally occur with high dosage and parenteral administration. 5) SUBSTANCE ABUSE DISORDERS 5A) ALCOL ABUSE AND DEPENDENCE DISORDER I) if severe Disorder and high patients motivation: Refer for Rehabilitation in Mathari Hospital inpatients (1200 Sh per day) II) Acute treatment of Withdrawal symptoms: IIa) Mild withdrawal: anxiety, insomnia, headache and agitation -Resolve without need for medication. IIb) Moderate/Severe Withdrawal: severe anxiety, agitation, insomnia, headache, tremors, sweating, tachycardia, hypertension, and hallucinations, seizures and delirium (delirium tremens). Diazepam 5-10 mg TDS 3/7 (up to 20 mg, depending on the severity of withdrawal) + + Thiamine 100 mg IM 5/7; then PO 6/12 Potassium, magnesium PO 3/52 and zinc supplementation Diazepam 5-10 mg BD 3/7 Patients should be placed in low stimulus environments (i.e quiet and dimly lit) and given adequate rehydration. Patients should not be given dextrose before thiamine. 5B) DRUG ABUSE AND DEPENDENCE DISORDER Refer to Mathari Hospital for psychiatric Consultation or in patients Rehabilitation (1200 Sh per day) 6) SCHIZOPHRENIA: Schizophrenia is the most common primary psychosis. It is a severe disorder that typically begins in late adolescence or early adulthood; it is found approximately equally in men and women, though the onset tends to be later in women, who also tend to have a better course and outcome of this disorder. Epidemiological surveys report a point prevalence of 0.4%. Schizophrenia is characterized by fundamental distortions in thinking and perception, and by inappropriate emotions. The disturbance involves the most basic functions that give the normal person a feeling of individuality, uniqueness and self-direction. Behaviour may be seriously disturbed during some phases of the disorder, leading to adverse social consequences. Delusions (strong belief in ideas that are false and without any basis in reality), and hallucinations (commonly auditory hallucinations, e.g. hearing voices) are typical psychotic features of this disorder. Individuals with schizophrenia are usually well oriented to person, place and time. Severely disturbed patients: Chlorpromazine 100-200 mg IM and then PO 100-200 12-24 hourly Mildly disturbed patients Haloperidol 5 mg TDS or Chlorpromazine 100 mg TDS Maintenance theraphy: Haloperidol 5-10 mg TDS or Chlorpromazine 100-200 TDS At onset of extrapiramidal effects: reduce dose and start on benzhexol 2,5-5 mg TDS - If concomitant affective symptomatology (alternance of MDE and hypomanic/manic episode) it’s a Schizoaffective Disorder : Add Carbamazepine as Maintenance theraphy (see 1b.I) with or without Haloperidol. These guidelines has been written for Ruaraka Uhai Neema Hospital (http://www.runeemahospital.org/) in collaboration between Jean-louis Aillon (Ruaraka Uhai Neema Hospital) and Prof. David M. Ndetei (African Mental Health Foundation: http://www.africamentalhealthfoundation.org/). They are an adaptation of the WHO guidelines for Mental health primary care (http://www.who.int/entity/mental_health/management/psychotropic/en/index.html) to the Kenyan context. The medicines used are the most cost-effective.